Can Mounjaro Cause Low Blood Pressure? What the Evidence Says

Is low blood pressure a recognised side effect of Mounjaro?

Not exactly. When you look at the published side-effect data from the SURMOUNT clinical programme and the Mounjaro SmPC, hypotension does not appear as a common or very common adverse event. What does appear is dizziness, and dizziness has more than one cause. The most frequent driver, particularly in the first four to eight weeks, is dehydration. Nausea, vomiting and reduced appetite mean many people drink less fluid than usual, and a dip in circulating blood volume can make you feel unsteady, especially when you move from lying or sitting to standing, a pattern clinicians call orthostatic hypotension.

A practical checking habit that takes under a minute: before you get out of bed in the morning, sit on the edge for ten seconds before standing. If the light-headedness only appears when you rush upright, dehydration or positional change is the far more likely culprit than a direct drug effect on your blood pressure. Sipping water steadily through the day helps more than gulping a large amount at once.

The NHS tirzepatide page lists dizziness among the less common side effects and recommends contacting a doctor if it is severe. That advice holds: occasional mild dizziness on standing is worth monitoring and managing; fainting or persistent light-headedness is a reason to call someone.

Does Mounjaro affect blood pressure in the other direction, can it raise it?

The evidence does not point that way either. In clinical trials, average blood pressure in participants either stayed broadly stable or fell modestly alongside weight loss. This matters because hypertension and obesity are closely linked, and one reason people with high blood pressure are sometimes prescribed Mounjaro is the reasonable expectation that sustained weight loss will reduce cardiovascular strain.

There is a subtler question embedded in the keyword mounjaro and high blood pressure: if your blood pressure was well-controlled by medication before you started, and then falls as you lose weight on Mounjaro, your existing antihypertensive prescription may become too strong. That is a genuine clinical consideration, and if you want to understand whether Mounjaro lowers blood pressure and what that means for people already on treatment, the evidence is explored in more detail on that page. This is not a reason to avoid Mounjaro; it is a reason to keep your GP updated and attend your scheduled medication reviews.

For a fuller look at how tirzepatide interacts with antihypertensive drugs specifically, the detail is covered on the Mounjaro and blood pressure medicines page.

Who is most likely to notice blood-pressure changes on Mounjaro?

A few groups are worth thinking about. People who are already taking medicines for high blood pressure face the scenario described above: effective weight loss may mean their current dose becomes more than they need. People who experience significant nausea and vomiting in the early weeks face the dehydration route to low readings. And people who are older or who already run blood pressure on the lower end of normal may notice positional symptoms more readily.

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as hypertension, so high blood pressure is actually one of the qualifying conditions that makes someone eligible, and there is a dedicated page covering how Mounjaro may help with blood pressure as part of that wider picture. Lower thresholds apply for some ethnic backgrounds under UK guidance. The prescriber at any regulated service, including our clinical team at nume, will look at your full medical history, including any blood pressure readings and current medications, before approving treatment.

Symptoms that go beyond mild dizziness (chest tightness, palpitations, confusion, or fainting) should be assessed medically the same day. You can also report suspected side effects to the MHRA via the Yellow Card scheme.

When should you actually call someone?

This is the question the other sections build towards, so it deserves a direct answer. Call your prescriber or GP promptly if: dizziness persists for more than a day or two and does not improve with better hydration; you faint or nearly faint; your heart is racing or pounding in a way that feels new; or you feel confused or cannot stand safely. None of these are common on Mounjaro, but they are not scenarios to sit with.

If you are monitoring your own blood pressure at home and readings drop below 90/60 mmHg consistently, that warrants a conversation with your prescriber. The Mounjaro treatment page gives a broader overview of what to expect during treatment, and the blood pressure medicines page covers what to discuss if you are already on antihypertensives. For anyone considering starting treatment and curious about the wider picture around how Mounjaro affects blood pressure over time, the evidence currently looks reassuring rather than concerning, but individual assessment is always the starting point.

If you would like a prescriber to review your specific history before you begin, speaking to our prescribers is the natural next step.